HOME › DRUGS › ADO-TRASTUZUMAB EMTANSINE
ACTIVE SUBSTANCE / INN

ADO-TRASTUZUMAB EMTANSINE

Brand name(s): KADCYLA
FDA LISTED
PRESCRIPTION
BLA125427
ACTIVE SUBSTANCE
Ado-Trastuzumab Emtansine
REGULATORS
FDA
SPONSORS / MAH
GENENTECH
TOTAL APPLICATIONS
1
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
KADCYLABLA125427GENENTECHPrescription

FULL INTELLIGENCE ON ADO-TRASTUZUMAB EMTANSINE

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →